BlackRock »

Entrada Therapeutics shares owned by BlackRock

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by BlackRock

Quarter filed Position value Share count Share price at filing
2023-09-30 $22M 1.4M 15.80
2023-06-30 $21M 1.4M 15.14
2023-03-31 $3.1M 212k 14.50
2022-12-31 $2.5M 188k 13.52
2022-06-30 $790k 65k 12.15